{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T16:43:22Z","timestamp":1774716202672,"version":"3.50.1"},"reference-count":106,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2021.682620","type":"journal-article","created":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T04:54:07Z","timestamp":1642481647000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["The Illusory Case for Treatment of an Invented Disease"],"prefix":"10.3389","volume":"12","author":[{"given":"David J.","family":"Handelsman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.5694\/mja13.10111","article-title":"Global Trends in Testosterone Prescribing, 2000-2011: Expanding the Spectrum of Prescription Drug Misuse","volume":"199","author":"Handelsman","year":"2013","journal-title":"Med J Aust"},{"key":"B2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1210\/endrev\/bnab001","article-title":"Androgen Misuse and Abuse","volume":"42","author":"Handelsman","year":"2021","journal-title":"Endocr Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)64118-1","article-title":"Note on the Effects Produced on Man by Subcutaneous Injections of a Liquid Obtained From the Testicles of Animals","volume":"134","author":"Brown-Sequard","year":"1889","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.1486.1411","article-title":"The British Medical Journal","volume":"1","year":"1889","journal-title":"Bmj"},{"key":"B5","article-title":"Editorial, Is There an Elixir of Life","volume":"121","year":"1889","journal-title":"Boston Med Surg J"},{"key":"B6","article-title":"Dr Brown-Sequard\u2019s \u201cElixir of Life\u201d","volume":"135","year":"1890","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2002.tb05014.x","article-title":"Brown-Sequard Revisited: A Lesson From History on the Placebo Effect of Androgen Treatment","volume":"177","author":"Cussons","year":"2002","journal-title":"Med J Aust"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0160-9327(03)00102-9","article-title":"\u2018Dr Steinach Coming to Make Old Young!\u2019: Sex Glands, Vasectomy and the Quest for Rejuvenation in the Roaring Twenties","volume":"27","author":"Sengoopta","year":"2003","journal-title":"Endeavour"},{"key":"B9","volume-title":"The Myth of Ponce De Le\u00f3n and the Fountain of Youth","author":"Greenspan","year":"2013"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.13391","article-title":"Disease Mongering of Age-Associated Declines in Testosterone and Growth Hormone Levels","volume":"63","author":"Perls","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1371\/journal.pmed.0030191","article-title":"The Fight Against Disease Mongering: Generating Knowledge for Action","volume":"3","author":"Moynihan","year":"2006","journal-title":"PloS Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2008.01814.x","article-title":"Disease Mongering: Expanding the Boundaries of Treatable Disease","volume":"38","author":"Doran","year":"2008","journal-title":"Intern Med J"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/andr.12770","article-title":"European Academy of Andrology (EAA) Guidelines on Investigation, Treatment and Monitoring of Functional Hypogonadism in Males: Endorsing Organization: European Society of Endocrinology","volume":"8","author":"Corona","year":"2020","journal-title":"Andrology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0601","article-title":"Investigation, Treatment and Monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA and ASA Recommendations","volume":"159","author":"Wang","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2020.760","article-title":"Current National and International Guidelines for the Management of Male Hypogonadism: Helping Clinicians to Navigate Variation in Diagnostic Criteria and Treatment Recommendations","volume":"35","author":"Al-Sharefi","year":"2020","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-3580","article-title":"A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management","volume":"102","author":"Grossmann","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.5694\/mja16.00393","article-title":"Endocrine Society of Australia Position Statement on Male Hypogonadism (Part 1): Assessment and Indications for Testosterone Therapy","volume":"205","author":"Yeap","year":"2016","journal-title":"Med J Aust"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.6892","article-title":"Promoting \u201cLow T\u201d: A Medical Writer\u2019s Perspective","volume":"173","author":"Braun","year":"2013","journal-title":"JAMA Internal Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4103\/1008-682X.137684","article-title":"The Emancipation of Testosterone From Niche Hormone to Multi-System Player","volume":"17","author":"Saad","year":"2015","journal-title":"Asian J Androl"},{"key":"B21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.urology.2015.11.034","article-title":"Controversies and Advances With Testosterone Therapy: A 40-Year Perspective","volume":"89","author":"Morgentaler","year":"2016","journal-title":"Urology"},{"key":"B22","volume-title":"Androgen Physiology, Pharmacology, Use and Misuse","author":"Handelsman","year":"2020"},{"key":"B23","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-44441-3_44","article-title":"Androgen Use, Misuse and Abuse","volume-title":"Endocrinology of the Testis and Male Reproduction","author":"Handelsman","year":"2017"},{"key":"B24","volume-title":"Minutes of the Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, September 17, 2014","year":"2014"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2006.00992.x","article-title":"Prevalence of Hypogonadism in Males Aged at Least 45 Years: The HIM Study","volume":"60","author":"Mulligan","year":"2006","journal-title":"Int J Clin Pract"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.0002-8614.2004.52413.x","article-title":"Changes in Sexual Function in Middle-Aged and Older Men: Longitudinal Data From the Massachusetts Male Aging Study","volume":"52","author":"Araujo","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1830","article-title":"Testosterone and Estradiol Among Older Men","volume":"91","author":"Orwoll","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3109\/13685538.2010.487553","article-title":"Prevalence, Incidence and Risk Factors of Testosterone Deficiency in a Population-Based Cohort of Men: Results From the Study of Health in Pomerania","volume":"13","author":"Haring","year":"2010","journal-title":"Aging Male"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908127","article-title":"Effect of Dutasteride on the Risk of Prostate Cancer","volume":"362","author":"Andriole","year":"2010","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1506632","article-title":"Testosterone and \u201cAge-Related Hypogonadism\u201d\u2013FDA Concerns","volume":"373","author":"Nguyen","year":"2015","journal-title":"N Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0911101","article-title":"Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men","volume":"363","author":"Wu","year":"2010","journal-title":"N Engl J Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2605.1999.00196.x","article-title":"Lack of Sexual Activity From Erectile Dysfunction is Associated With a Reversible Reduction in Serum Testosterone","volume":"22","author":"Jannini","year":"1999","journal-title":"Int J Androl"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02108.x","article-title":"Type V Phosphodiesterase Inhibitor Treatments for Erectile Dysfunction Increase Testosterone Levels","volume":"61","author":"Carosa","year":"2004","journal-title":"Clin Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-157-10-201211200-00004","article-title":"Effect of Testosterone Replacement on Response to Sildenafil Citrate in Men With Erectile Dysfunction: A Parallel, Randomized Trial","volume":"157","author":"Spitzer","year":"2012","journal-title":"Ann Intern Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-4104","article-title":"The Longitudinal Relationship of Sexual Function and Androgen Status in Older Men: The Concord Health and Ageing in Men Project","volume":"100","author":"Hsu","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-1100","article-title":"Six Months of Daily Treatment With Vardenafil Improves Parameters of Endothelial Inflammation and of Hypogonadism in Male Patients With Type 2 Diabetes and Erectile Dysfunction: A Randomized, Double-Blind, Prospective Trial","volume":"174","author":"Santi","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/cen.13723","article-title":"Hypogonadism and Male Obesity: Focus on Unresolved Questions","volume":"89","author":"Grossmann","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0118","article-title":"Low Testosterone in Men With Type 2 Diabetes: Significance and Treatment","volume":"96","author":"Grossmann","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1210\/er.2017-00025","article-title":"A Reappraisal of Testosterone\u2019s Binding in Circulation: Physiological and Clinical Implications","volume":"38","author":"Goldman","year":"2017","journal-title":"Endocr Rev"},{"key":"B40","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1210\/er.2017-00171","article-title":"Free Testosterone: Pumping Up the Tires or Ending the Free Ride","volume":"38","author":"Handelsman","year":"2017","journal-title":"Endocr Rev"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glx170","article-title":"Evaluating Calculated Free Testosterone as a Predictor of Morbidity and Mortality Independent of Testosterone for Cross-Sectional and 5-Year Longitudinal Health Outcomes in Older Men: The Concord Health and Ageing in Men Project","volume":"73","author":"Hsu","year":"2018","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B42","volume-title":"Assay of Thyroid Hormones and Related Substances","author":"Spencer","year":"2017"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-00468","article-title":"Provider and Site-Level Determinants of Testosterone Prescribing in the Veterans Healthcare System","volume":"102","author":"Jasuja","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000336","article-title":"Patterns of Testosterone Prescription Overuse","volume":"24","author":"Jasuja","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-016-3940-7","article-title":"Who Gets Testosterone? Patient Characteristics Associated With Testosterone Prescribing in the Veteran Affairs System: A Cross-Sectional Study","volume":"32","author":"Jasuja","year":"2017","journal-title":"J Gen Intern Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000398","article-title":"Ascertainment of Testosterone Prescribing Practices in the VA","volume":"53","author":"Jasuja","year":"2015","journal-title":"Med Care"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-00325","article-title":"Nonthyroidal Illness Syndrome Across the Ages","volume":"3","author":"Langouche","year":"2019","journal-title":"J Endocr Soc"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2010.02395.x","article-title":"The Nonthyroidal Illness Syndrome in the Non-Critically Ill Patient","volume":"41","author":"Pappa","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"B49","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.ecl.2007.04.007","article-title":"The Nonthyroidal Illness Syndrome","volume":"36","author":"Adler","year":"2007","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ccc.2005.10.001","article-title":"Non-Thyroidal Illness Syndrome is a Manifestation of Hypothalamic-Pituitary Dysfunction, and in View of Current Evidence, Should be Treated With Appropriate Replacement Therapies","volume":"22","author":"De Groot","year":"2006","journal-title":"Crit Care Clinics"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.1.5364","article-title":"Dangerous Dogmas in Medicine: The Nonthyroidal Illness Syndrome","volume":"84","author":"De Groot","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.5.5677-2","article-title":"Trading One \u201cDangerous Dogma\u201d for Another? Thyroid Hormone Treatment of the \u201cEuthyroid Sick Syndrome\u201d","volume":"84","author":"Wartofsky","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2012.04432.x","article-title":"Serum Testosterone, Dihydrotestosterone and Estradiol Concentrations in Older Men Self-Reporting Very Good Health: The Healthy Man Study","volume":"77","author":"Sartorius","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3842","article-title":"Longitudinal Changes in Testosterone Over Five Years in Community-Dwelling Men","volume":"98","author":"Shi","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1972","article-title":"Hypothalamic-Pituitary-Testicular Axis Disruptions in Older Men Are Differentially Linked to Age and Modifiable Risk Factors: The European Male Aging Study","volume":"93","author":"Wu","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506119","article-title":"I. Testosterone Trials, Effects of Testosterone Treatment in Older Men","volume":"374","author":"Snyder","year":"2016","journal-title":"N Engl J Med"},{"key":"B57","volume-title":"Testosterone and Aging: Clinical Research Directions, Institute of Medicine","author":"Liverman","year":"2004"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women\u2019s Health Initiative Randomized Controlled Trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1645","article-title":"Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels","volume":"101","author":"Cunningham","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.9539","article-title":"Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial","volume":"177","author":"Snyder","year":"2017","journal-title":"JAMA Intern Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.9540","article-title":"Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial","volume":"177","author":"Roy","year":"2017","journal-title":"JAMA Intern Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.21043","article-title":"Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone","volume":"317","author":"Budoff","year":"2017","journal-title":"JAMA"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1210\/er.2017-00234","article-title":"Lessons From the Testosterone Trials","volume":"39","author":"Snyder","year":"2018","journal-title":"Endocr Rev"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1600196","article-title":"Establishing a Framework\u2013Does Testosterone Supplementation Help Older Men","volume":"374","author":"Orwoll","year":"2016","journal-title":"N Engl J Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1001\/jama.2017.0129","article-title":"Testosterone and Male Aging: Faltering Hope for Rejuvenation","volume":"317","author":"Handelsman","year":"2017","journal-title":"JAMA"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glz195","article-title":"Testosterone for Androgen Deficiency-Like Symptoms in Men Without Pathologic Hypogonadism: A Randomized, Placebo-Controlled Cross-Over With Masked Choice Extension Clinical Trial","volume":"75","author":"Mok","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12608","article-title":"Long-Term Treatment Patterns of Testosterone Replacement Medications","volume":"11","author":"Donatucci","year":"2014","journal-title":"J Sex Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12114","article-title":"Medication Adherence and Treatment Patterns for Hypogonadal Patients Treated With Topical Testosterone Therapy: A Retrospective Medical Claims Analysis","volume":"10","author":"Schoenfeld","year":"2013","journal-title":"J Sex Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00020","article-title":"Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance","volume":"39","author":"Handelsman","year":"2018","journal-title":"Endocr Rev"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1184","article-title":"Older Men are as Responsive as Young Men to the Anabolic Effects of Graded Doses of Testosterone on the Skeletal Muscle","volume":"90","author":"Bhasin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM199607043350101","article-title":"The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal Men","volume":"335","author":"Bhasin","year":"1996","journal-title":"N Engl J Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1206168","article-title":"Gonadal Steroids and Body Composition, Strength, and Sexual Function in Men","volume":"369","author":"Finkelstein","year":"2013","journal-title":"N Engl J Med"},{"key":"B73","first-page":"372","article-title":"Androgen Therapy in Non-Gonadal Disease","volume-title":"Testosterone: Action, Deficiency and Substitution","author":"Handelsman","year":"2011"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00110","article-title":"Testosterone Supplementation in Patients With Chronic Heart Failure: A Meta-Analysis of Randomized Controlled Trials","volume":"11","author":"Tao","year":"2020","journal-title":"Front Endocrinol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"i5968","DOI":"10.1136\/bmj.i5968","article-title":"Testosterone Treatment and Risk of Venous Thromboembolism: Population Based Case-Control Study","volume":"355","author":"Martinez","year":"2016","journal-title":"BMJ"},{"key":"B76","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.thromres.2018.10.023","article-title":"Testosterone Therapy and Venous Thromboembolism: A Systematic Review and Meta-Analysis","volume":"172","author":"Houghton","year":"2018","journal-title":"Thromb Res"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2018.04.641","article-title":"Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies","volume":"15","author":"Corona","year":"2018","journal-title":"J Sex Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1530\/EJE-11-0447","article-title":"Hypogonadism as a Risk Factor for Cardiovascular Mortality in Men: A Meta-Analytic Study","volume":"165","author":"Corona","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1137","article-title":"Clinical Review: Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis","volume":"96","author":"Araujo","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1970","article-title":"Beneficial and Adverse Effects of Testosterone on the Cardiovascular System in Men","volume":"98","author":"Ruige","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.280386","article-title":"Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stroke in Men With Low Testosterone Levels","volume":"310","author":"Vigen","year":"2013","journal-title":"JAMA"},{"key":"B82","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.amjmed.2016.09.017","article-title":"Cardiovascular Risks of Exogenous Testosterone Use Among Men: A Systematic Review and Meta-Analysis","volume":"130","author":"Alexander","year":"2017","journal-title":"Am J Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13084","article-title":"Testosterone Therapy, Association With Age, Initiation and Mode of Therapy With Cardiovascular Events: A Systematic Review","volume":"85","author":"Albert","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B84","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12916-014-0211-5","article-title":"Cardiovascular Risks and Elevation of Serum DHT Vary by Route of Testosterone Administration: A Systematic Review and Meta-Analysis","volume":"12","author":"Borst","year":"2014","journal-title":"BMC Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2014.950653","article-title":"Cardiovascular Risk Associated With Testosterone-Boosting Medications: A Systematic Review and Meta-Analysis","volume":"13","author":"Corona","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"B86","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1741-7015-11-108","article-title":"Testosterone Therapy and Cardiovascular Events Among Men: A Systematic Review and Meta-Analysis of Placebo-Controlled Randomized Trials","volume":"11","author":"Xu","year":"2013","journal-title":"BMC Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2575","article-title":"Clinical Review 1: Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis","volume":"95","author":"Fernandez-Balsells","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B88","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0025-6196(11)60964-6","article-title":"Testosterone and Cardiovascular Risk in Men: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials","volume":"82","author":"Haddad","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e85805","DOI":"10.1371\/journal.pone.0085805","article-title":"Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men","volume":"9","author":"Finkle","year":"2014","journal-title":"PloS One"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(16)30215-7","article-title":"Association Between Exogenous Testosterone and Cardiovascular Events: An Overview of Systematic Reviews","volume":"4","author":"Onasanya","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1741-7015-11-57","article-title":"The Effect of Statins on Testosterone in Men and Women, A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"11","author":"Schooling","year":"2013","journal-title":"BMC Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djm323","article-title":"Endogenous Sex Hormones and Prostate Cancer: A Collaborative Analysis of 18 Prospective Studies","volume":"100","author":"Roddam","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13417","article-title":"Endogenous and Exogenous Testosterone and the Risk of Prostate Cancer and Increased Prostate Specific Antigen (PSA): A Meta-Analysis","volume":"118","author":"Boyle","year":"2016","journal-title":"BJU Int"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2013.12.010","article-title":"Synthesis of New Potent Agonistic Analogs of Growth Hormone-Releasing Hormone (GHRH) and Evaluation of Their Endocrine and Cardiac Activities","volume":"52","author":"Cai","year":"2014","journal-title":"Peptides"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.03.141","article-title":"Urologic Diseases in America Project: Benign Prostatic Hyperplasia","volume":"179","author":"Wei","year":"2008","journal-title":"J Urol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2006.04.019","article-title":"Prevalence, Severity, and Health Correlates of Lower Urinary Tract Symptoms Among Older Men: The MrOS Study","volume":"68","author":"Taylor","year":"2006","journal-title":"Urology"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.21.2381","article-title":"Prevalence of Lower Urinary Tract Symptoms and Effect on Quality of Life in a Racially and Ethnically Diverse Random Sample: The Boston Area Community Health (BACH) Survey","volume":"166","author":"Kupelian","year":"2006","journal-title":"Arch Intern Med"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2008.03.057","article-title":"Prevalence and Characteristics of Lower Urinary Tract Symptoms in Men Aged > or = 80 Years","volume":"72","author":"Parsons","year":"2008","journal-title":"Urology"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13578","article-title":"Testosterone Treatment Is Not Associated With Increased Risk of Prostate Cancer or Worsening of Lower Urinary Tract Symptoms: Prostate Health Outcomes in the Registry of Hypogonadism in Men","volume":"119","author":"Debruyne","year":"2017","journal-title":"BJU Int"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.sxmr.2018.10.006","article-title":"Testosterone and Benign Prostatic Hyperplasia","volume":"7","author":"Rastrelli","year":"2019","journal-title":"Sex Med Rev"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.01.043","article-title":"Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms: A Systematic Review and Meta-Analysis","volume":"69","author":"Kohn","year":"2016","journal-title":"Eur Urol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5080","article-title":"Pharmacoepidemiology of Testosterone: Impact of Reimbursement Policy on Curbing Off-Label Prescribing","volume":"29","author":"Handelsman","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1007\/s40279-017-0709-z","article-title":"Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis","volume":"47","author":"Christou","year":"2017","journal-title":"Sports Med"},{"key":"B104","doi-asserted-by":"publisher","first-page":"e0161208","DOI":"10.1371\/journal.pone.0161208","article-title":"Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years After Cessation: A Case-Control Study","volume":"11","author":"Rasmussen","year":"2016","journal-title":"PloS One"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz324","article-title":"Rate and Extent of Recovery From Reproductive and Cardiac Dysfunction Due to Androgen Abuse in Men","volume":"105","author":"Shankara-Narayana","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4284","article-title":"Pharmacoepidemiology of Testosterone: Curbing Off-Label Prescribing","volume":"26","author":"Handelsman","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.682620\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T04:54:17Z","timestamp":1642481657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.682620\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,18]]},"references-count":106,"alternative-id":["10.3389\/fendo.2021.682620"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.682620","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,18]]},"article-number":"682620"}}